Gainers
- T2 Biosystems TTOO shares increased by 15.45% to $0.14. The company's market cap stands at $23.9 million.
- Infinity Pharmaceuticals INFI shares moved upwards by 14.86% to $0.85. The market value of their outstanding shares is at $75.7 million. As per the news, the Q2 earnings report came out yesterday.
- Aethlon Medical AEMD shares moved upwards by 14.5% to $1.5. The market value of their outstanding shares is at $24.9 million. The company's, Q1 earnings came out yesterday.
- Catalyst Pharmaceuticals CPRX stock moved upwards by 12.25% to $11.9. The market value of their outstanding shares is at $1.2 billion. As per the news, the Q2 earnings report came out yesterday.
- Codex DNA DNAY shares rose 11.05% to $2.2. The company's market cap stands at $64.8 million. As per the press release, Q2 earnings came out yesterday.
Losers
- OptimizeRx OPRX stock declined by 22.7% to $17.2 during Wednesday's pre-market session. The company's market cap stands at $312.2 million. As per the press release, Q2 earnings came out yesterday.
- Graybug Vision GRAY shares declined by 14.53% to $1.0. The company's market cap stands at $21.3 million.
- Berkeley Lights BLI stock decreased by 14.47% to $4.25. The company's market cap stands at $288.3 million. As per the press release, Q2 earnings came out yesterday.
- Akanda AKAN shares declined by 14.4% to $1.07. The company's market cap stands at $32.9 million.
- Vir Biotechnology VIR shares fell 13.91% to $24.83. The market value of their outstanding shares is at $3.2 billion. As per the press release, Q2 earnings came out yesterday.
- Evotec EVO shares decreased by 13.38% to $12.24. The company's market cap stands at $4.3 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in